Monograph Details
|
|
Ob/Gyn
> Labor and delivery
|
|
PREPIDIL |
| Manufacturer |
|
Pfizer Labs |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
PGE2 oxytocic. |
| Generic Name |
|
Dinoprostone 0.5mg/3g; endocervical gel. |
| Indications |
|
Ripening an unfavorable cervix in pregnant women at or near term. |
| Children |
|
Not applicable. |
| Adults |
|
See literature. |
| Contraindications |
|
Where oxytocics or prolonged uterine contractions are inappropriate, including: history of cesarean section, major uterine surgery, presence of cephalopelvic disproportion, difficult labor, traumatic delivery, 6 or more previous term pregnancies, nonvertex presentation, hyperactive or hypertonic uterine patterns, fetal distress where delivery is not imminent. Ruptured membranes. Placenta previa or unexplained vaginal bleeding. When vaginal delivery is not indicated. Concomitant oxytocics. |
| Precautions |
|
For hospital use only when immediate intensive care and acute surgical facilities can be provided. Avoid contact with skin. Monitor uterine activity, fetal status, cervix. History of/or asthma. Glaucoma or increased intraocular pressure. Renal or hepatic dysfunction. Pregnancy (Cat.C). |
| Interactions |
|
Potentiates oxytocics. Oxytocin: a dosing interval of 6–12 hrs is needed, if used following Prepidil administration. |
| Adverse Reactions |
|
Maternal: Uterine rupture, uterine contraction abnormality, GI upset, back pain, warm feeling in vagina, fever, premature rupture of membranes. Fetal: Heart rate abnormality, fetal depression, fetal acidosis. Amnionitis and intrauterine fetal sepsis associated with extra-intrauterine administration. |
| How Supplied |
|
Prefilled-syringe applicator (w. catheters)—5 |
|
|
|
|
